Statistical Models and Bioterrorism: Application to the U.S. Anthrax Outbreak

Journal of the American Statistical Association

Volumn 98, Issue 464, 2003, Pages 781-788

  Brookmeyer, Ron ^a   Blades, Natalie ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Anthrax; Epidemiology; Infectious disease; Likelihood

Indexed keywords

EID: 1142265338     PISSN: 01621459     EISSN: None     Source Type: Journal    
DOI: 10.1198/016214503000000701     Document Type: Review

References (14)

1. Brachman, P. S. (1980), "Inhalation Anthrax," Annals of the New York Academy, 353, 83-93.
2. Brookmeyer, R., and Blades, N. (2002), "Prevention of Inhalational Anthrax in the U.S. Outbreak," Science, 295, 1861.
3. Brookmeyer, R., Blades, N., Hugh-Jones, M., and Henderson, D. (2001), "The Statistical Analysis of Truncated Data: Application to the Sverdlovsk Anthrax Outbreak," Biostatistics, 2, 233-247.
4. Brookmeyer, R., and Gail, M. H. (1994), AIDS Epidemiology: A Quantitative Approach, London: Oxford University Press.
5. Brookmeyer, R., Johnson, E., and Bollinger, R. (2003), "Modeling the Optimum Duration of Antibiotic Prophylaxis in an Anthrax Outbreak," Proceedings of the National Academy of Sciences, 100, 10129-10132.
6. Bush, L. M., Abrams, B. H., Beall, A., and Johnson, C. C. (2001), "Index Cases of Fatal Inhalational Anthrax Due to Bioterrorism in the United States," New England Journal of Medicine, 345, 1607-1610.
7. Cieslak, T., and Eitzen, E. (2000), "Clinical and Epidemiologic Principles of Anthrax," Emerging Infectious Diseases, 5, 552.
8. Donnelly, C. A., and Ferguson, N. M. (2000), Statistical Aspects of BSE and vCJD: Models for Epidemics, New York: Chapman & Hall/CRC Press.
9. Guillemin, J. (1999), Anthrax: The Investigation of a Lethal Outbreak, Berkeley, CA: University of California Press.
10. Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M., Eitzen, E., Fried-lander, A., Haver, J., McDade, J., Osterholm, M., O'Toole, T., Parker, G., Pevi, T., Russell, P., and Tonat, K. (for the Working Group on Civilian Biodefense) (1999), "Anthrax as a Biological Weapon: Medical and Public Health Management," Journal of the American Medical Association, 281, 1735-1745.
11. Jernigan, J. A., Stephen, D. S., Ashford, D. A., Omenaca, C., Martin, S. T., Galbraith, M., Tapper, M., Fisk, T. L., Zaki, S., Popovic, T., Meyer, R. F., Quinn, C. P., Harper, S. A., Scott, K. F., Sejvar, J. J., Shepard, C. W., McConnell, M., Guarner, J., Shieh, W.-J., Malecki, J. M., Gerberding, J. L., Hughes, J. M., Perkins, B. A., and Anthrax Bioterrorism Investigation Team (2001), "Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States," Emerging Infectious Diseases, 7, 933.
12. Meselson, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Popova, I., Shelokov, A., and Yampolskaya, O. (1994), "The Sverdlovsk Anthrax Outbreak of 1979," Science, 266, 1202-1208.
13. Morbidity and Mortality Weekly Reports (2001). Available at www.cdc.gov/mmwr/indexbt.html.
14. Sartwell, P. E. (1950), "The Distribution of Incubation Periods of Infectious Diseases," American Journal of Hygiene, 51, 310-318.